Bone morphogenetic protein 4 regulates microRNAs miR-494 and miR-126–5p in control of endothelial cell function in angiogenesis

Summary

MicroRNAs are small non-coding RNAs that negatively regulate posttranscriptional gene expression. Several microRNAs have been described to regulate the process of angiogenesis. Previously, we have shown that bone morphogenetic protein 4 (BMP4) increased the proangiogenic activity of endothelial cells. In this project, we now investigated how the pro-angiogenic BMP4 effect is mediated by microRNAs. First, we performed a microRNA array with BMP4-stimulated human umbilical vein endothelial cells (HUVECs). Among the topregulated microRNAs, we detected a decreased expression of miR-494 and increased expression of miR-126–5p. Next, we analysed the canonical Smad and alternative signalling pathways, through which BMP4 would regulate miR-126–5p and miR-494 expression. Furthermore, the functional effect of miR-494 and miR-126–5p on endothelial cells was investigated. MicroRNA-494 overexpression decreased endothelial cell proliferation, migration and sprout formation. Consistently, miR-494 inhibition increased endothelial cell function. As potential miR-494 targets, bFGF and BMP endothelial cell precursorderived regulator (BMPER) were identified and confirmed by western blot. Luciferase assays showed direct miR-494 binding in BMPER 3’UTR. In contrast, miR-126–5p overexpression increased pro-angiogenic endothelial cell behaviour and, accordingly, miR-126–5p inhibition decreased endothelial cell function. As a direct miR-126–5p target we identified the anti-angiogenic thrombospondin-1 which was confirmed by western blot analysis and luciferase assays. In the Matrigel plug assay application of antagomiR-494 increased endothelial cell ingrowth, whereas antagomiR-126–5p treatment decreased cell ingrowth in vivo. Taken together, through differential regulation of the anti-angiomiR-494 and the angiomiR-126–5p by BMP4 both microRNAs contribute to the pro-angiogenic BMP4 effect on endothelial cells.

Supplementary Material to this article is available online at www.thrombosis-online.com.

Keywords

BMP4 - microRNAs - angiogenesis - endothelial cells

• References

• 1 Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms Circ Res 2007; 100: 158-173
• 2 Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011; 146: 873-887
• 3 Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nature Rev Drug Discov 2009; 8: 235-253
• 4 Presta M, Dell’Era P, Mitola S. et al. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 2005; 16: 159-178
• 5 Bornstein P. Thrombospondins function as regulators of angiogenesis. J Cell Commun Signal 2009; 3: 189-200
• 6 Landskroner-Eiger S, Moneke I, Sessa WC. miRNAs as modulators of angiogenesis. Cold Spring Harbor Persp Med 2013; 3: a006643
• 7 Wang S, Olson EN. AngiomiRs--key regulators of angiogenesis. Curr Opin Gen Devel 2009; 19: 205-211
• 8 Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297
• 9 Kuehbacher A, Urbich C, Zeiher AM. et al. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 2007; 101: 59-68
• 10 Suarez Y, Fernandez-Hernando C, Pober JS. et al. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 2007; 100: 1164-1173
• 11 Yang WJ, Yang DD, Na S. et al. Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem 2005; 280: 9330-9335
• 12 Fish JE, Santoro MM, Morton SU. et al. miR-126 regulates angiogenic signaling and vascular integrity. Develop Cell 2008; 15: 272-284
• 13 Wang S, Aurora AB, Johnson BA. et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Develop Cell 2008; 15: 261-271
• 14 Chang SH, Hla T. Post-transcriptional gene regulation by HuR and microRNAs in angiogenesis. Curr Opin Hematol 2014; 21: 235-240
• 15 Hergenreider E, Heydt S, Treguer K. et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nature Cell Biol 2012; 14: 249-256
• 16 Mocharla P, Briand S, Giannotti G. et al. AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics. Blood 2013; 121: 226-236
• 17 Schmierer B, Hill CS. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007; 8: 970-982
• 18 Garcia de Vinuesa A, Abdelilah-Seyfried S, Knaus P. et al. BMP signaling in vascular biology and dysfunction. Cytokine Growth Factor Rev 2016; 27: 65-79
• 19 David L, Feige JJ, Bailly S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 2009; 20: 203-212
• 20 Goumans MJ, Liu Z, ten Dijke P. TGF-beta signaling in vascular biology and dysfunction. Cell Res 2009; 19: 116-127
• 21 Moya IM, Umans L, Maas E. et al. Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades. Develop Cell 2012; 22: 501-514
• 22 Herrera B, Inman GJ. A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum. BMC Cell Biol 2009; 10: 20
• 23 Son JW, Jang EH, Kim MK. et al. Serum BMP-4 levels in relation to arterial stiffness and carotid atherosclerosis in patients with Type 2 diabetes. Biomark Med 2011; 5: 827-835
• 24 Hata A, Kang H. Functions of the bone morphogenetic protein signaling pathway through microRNAs (review). Intern J Mol Med 2015; 35: 563-568
• 25 Davis BN, Hilyard AC, Nguyen PH. et al. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 2010; 39: 373-384
• 26 Davis BN, Hilyard AC, Lagna G. et al. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008; 454: 56-61
• 27 Wang J, Greene SB, Bonilla-Claudio M. et al. Bmp signaling regulates myocardial differentiation from cardiac progenitors through a MicroRNA-mediated mechanism. Develop Cell 2010; 19: 903-912
• 28 Zhou Q, Heinke J, Vargas A. et al. ERK signaling is a central regulator for BMP-4 dependent capillary sprouting. Cardiovasc Res 2007; 76: 390-399
• 29 Elgjo RF, Henriksen T, Evensen SA. Ultrastructural identification of umbilical cord vein endothelium in situ and in culture. Cell Tissue Res 1975; 162: 49-59
• 30 Thum T, Galuppo P, Wolf C. et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007; 116: 258-267
• 31 Wong ML, Medrano JF. Real-time PCR for mRNA quantitation. Biotechniques 2005; 39: 75-85
• 32 Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-1108
• 33 Heinke J, Patterson C, Moser M. Life is a pattern: vascular assembly within the embryo. Frontiers Biosci 2012; 4: 2269-2288
• 34 Heinke J, Wehofsits L, Zhou Q. et al. BMPER Is an Endothelial Cell Regulator and Controls Bone Morphogenetic Protein-4-Dependent Angiogenesis. Circ Res 2008; 103: 804-812
• 35 Esser JS, Rahner S, Deckler M. et al. Fibroblast growth factor signaling pathway in endothelial cells is activated by BMPER to promote angiogenesis. Arterioscler Thromb Vasc Biol 2015; 35: 358-367
• 36 Urbich C, Kaluza D, Fromel T. et al. MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood 2012; 119: 1607-1616
• 37 Bridge G, Monteiro R, Henderson S. et al. The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. Blood 2012; 120: 5063-5072
• 38 Guo X, Wang XF. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 2009; 19: 71-88
• 39 Dyer LA, Pi X, Patterson C. The role of BMPs in endothelial cell function and dysfunction. Trends Endocrinol Metab 2014; 25: 472-480
• 40 Anderson L, Lowery JW, Frank DB. et al. Bmp2 and Bmp4 exert opposing effects in hypoxic pulmonary hypertension. Am J Physiol Regul Integr Comp Physiol 2010; 298: R833-842
• 41 Morrell NW, Bloch DB, Ten Dijke P. et al. Targeting BMP signalling in cardiovascular disease and anaemia. Nat Rev Cardiol 2016; 13: 106-120
• 42 Pardali E, Ten Dijke P. TGFbeta signaling and cardiovascular diseases. Int J Biol Sci 2012; 8: 195-213
• 43 Heinke J, Juschkat M, Charlet A. et al. Antagonism and synergy between extracellular BMP modulators Tsg and BMPER balance blood vessel formation. J Cell Sci 2013; 126: 3082-3094
• 44 Blahna MT, Hata A. Regulation of miRNA biogenesis as an integrated component of growth factor signaling. Curr Opin Cell Biol 2013; 25: 233-240
• 45 Wang X, Zhang X, Ren XP. et al. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischaemia/reperfusion-induced cardiac injury. Circulation 2010; 122: 1308-1318
• 46 Mao G, Liu Y, Fang X. et al. Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer. Angiogenesis 2015; 18: 373-382
• 47 Welten SM, Bastiaansen AJ, de Jong RC. et al. Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 increases neovascularisation and blood flow recovery after ischaemia. Circ Res 2014; 115: 696-708
• 48 Schober A, Nazari-Jahantigh M, Wei Y. et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med 2014; 20: 368-376
• 49 Lawler PR, Lawler J. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harbor Perspect Med 2012; 2: a006627